Literature DB >> 18430060

Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats.

Kayoko Miyata1, Naro Ohashi, Yuki Suzaki, Akemi Katsurada, Hiroyuki Kobori.   

Abstract

1. The present study was performed to test the hypothesis that the reactive oxygen species (ROS)-angiotensinogen (AGT)-renin angiotensin system (RAS) axis is sequentially activated in the development of diabetic nephropathy in Zucker diabetic fatty (ZDF) obese rats. 2. Genetic pairs of male ZDF obese and control ZDF lean rats (n = 12 of each species) were killed every 3 weeks from 12 to 21 weeks of age (n = 6 at each time point). 3. The ZDF obese rats developed diabetes mellitus at 12 weeks. At that time, urinary excretion rates of 8-isoprostane were similar between the groups; however, urinary 8-isoprostane levels were significantly increased at 15 weeks in ZDF obese rats compared with controls (36 +/- 6 vs 15 +/- 2 ng/day, respectively). At 15 weeks, protein levels of cortical angiotensinogen were similar between groups; however, cortical angiotensinogen levels were significantly increased at 18 weeks in ZDF obese rats compared with controls (relative ratio of 2.32 +/- 0.21 vs 1.00 +/- 0.20, respectively). At 12 weeks, angiotensin (Ang) II-like immunoreactivity was similar between groups in both the glomeruli and tubules; however, AngII-like immunoreactivity was increased significantly at 21 weeks in ZDF obese rats compared with controls (relative ratios of 1.98 +/- 0.55 vs 1.00 +/- 0.03, respectively, for glomeruli and 1.58 +/- 0.16 vs 1.00 +/- 0.13, respectively, for tubules). Moreover, at 21 weeks, the desmin-positive area in the glomeruli (0.63 +/- 0.08 vs 0.22 +/- 0.05%) and Masson's trichrome stain-positive area in the interstitium (4.97 +/- 0.05 vs 3.18 +/- 0.41%) were significantly increased in ZDF obese rats compared with controls, even though these differences had not been observed earlier. 4. These data suggest that the sequential activation of the ROS-AGT-RAS axis plays an important role in the development of diabetic nephropathy in ZDF obese rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18430060      PMCID: PMC2575127          DOI: 10.1111/j.1440-1681.2008.04938.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  47 in total

1.  Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.

Authors:  Tusty-Jiuan Hsieh; Pierre Fustier; Chih-Chang Wei; Shao-Ling Zhang; Janos G Filep; Shiow-Shiu Tang; Julie R Ingelfinger; I George Fantus; Pavel Hamet; John S D Chan
Journal:  J Endocrinol       Date:  2004-12       Impact factor: 4.286

2.  Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

Authors:  Yuri Ozawa; Hiroyuki Kobori; Yuki Suzaki; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-27

3.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

4.  Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Akira Nishiyama
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

5.  Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.

Authors:  Yuri Ozawa; Hiroyuki Kobori
Journal:  Am J Physiol Renal Physiol       Date:  2007-04-04

6.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Authors:  Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

7.  Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.

Authors:  Yukiko Nagai; Li Yao; Hiroyuki Kobori; Kayoko Miyata; Yuri Ozawa; Akira Miyatake; Tokihito Yukimura; Takatomi Shokoji; Shoji Kimura; Hideyasu Kiyomoto; Masakazu Kohno; Youichi Abe; Akira Nishiyama
Journal:  J Am Soc Nephrol       Date:  2005-01-12       Impact factor: 10.121

Review 8.  The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

Authors:  Hiroyuki Kobori; Masaomi Nangaku; L Gabriel Navar; Akira Nishiyama
Journal:  Pharmacol Rev       Date:  2007-09       Impact factor: 25.468

9.  Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Yuri Ozawa; Ryousuke Satou; Kayoko Miyata; Naoki Hase; Yuki Suzaki; Tatsuya Shoji
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

10.  Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice.

Authors:  M-L Brezniceanu; F Liu; C-C Wei; S Tran; S Sachetelli; S-L Zhang; D-F Guo; J G Filep; J R Ingelfinger; J S D Chan
Journal:  Kidney Int       Date:  2007-03-07       Impact factor: 10.612

View more
  48 in total

1.  Urinary angiotensinogen increases in the absence of overt renal injury in high fat diet-induced type 2 diabetic mice.

Authors:  Virginia Reverte; Venkateswara R Gogulamudi; Carla B Rosales; Diego C Musial; Sabrina R Gonsalez; Alberto J Parra-Vitela; Michelle Galeas-Pena; Venkata N Sure; Bruna Visniauskas; Sarah H Lindsey; Prasad V G Katakam; Minolfa C Prieto
Journal:  J Diabetes Complications       Date:  2019-10-05       Impact factor: 2.852

Review 2.  Intratubular renin-angiotensin system in hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa C Prieto; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

3.  Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy.

Authors:  Marie-Luise Brezniceanu; Cara J Lau; Nicolas Godin; Isabelle Chénier; Alain Duclos; Jean Ethier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 10.121

4.  Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes.

Authors:  Toshie Saito; Maki Urushihara; Yumiko Kotani; Shoji Kagami; Hiroyuki Kobori
Journal:  Am J Med Sci       Date:  2009-12       Impact factor: 2.378

5.  Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.

Authors:  T Cooper Woods; Ryousuke Satou; Kayoko Miyata; Akemi Katsurada; Courtney M Dugas; Natasha C Klingenberg; Vivian A Fonseca; L Gabriel Navar
Journal:  Am J Nephrol       Date:  2019-03-28       Impact factor: 3.754

6.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

7.  Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.

Authors:  Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Maki Urushihara; Hiroyuki Kobori
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-03-02       Impact factor: 2.557

8.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

9.  Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats.

Authors:  Weijian Shao; Kayoko Miyata; Akemi Katsurada; Ryousuke Satou; Dale M Seth; Carla B Rosales; Minolfa C Prieto; Kenneth D Mitchell; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

10.  Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.

Authors:  Sayaka Ishigaki; Naro Ohashi; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Masafumi Ono; Yukitoshi Sakao; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2016-01-07       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.